Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P21817: Variant p.Met2423Lys

Ryanodine receptor 1
Gene: RYR1
Feedback?
Variant information Variant position: help 2423 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Methionine (M) to Lysine (K) at position 2423 (M2423K, p.Met2423Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (M) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In CMYP1B. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 2423 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 5038 The length of the canonical sequence.
Location on the sequence: help REHFGEEPPEENRVHLGHAI M SFYAALIDLLGRCAPEMHLI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         REHFGEEPPEENRVHLGHAIMSFYAALIDLLGRCAPEMHLI

Mouse                         REHFGEEPPEENRVHLGHAIMSFYAALIDLLGRCAPETHLI

Rat                           REHFGEEPPEENRVHLGHAIMSFYAALIDLLGRCAPEMHLI

Pig                           REHFGEEPPEENRVHLGHAIMSFYAALIDLLGRCAPEMHLI

Rabbit                        REHFGEEPPEENRVHLGHAIMSFYAALIDLLGRCAPEMHLI
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 5038 Ryanodine receptor 1
Topological domain 1 – 4559 Cytoplasmic
Region 841 – 2959 6 X approximate repeats



Literature citations
Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.
Jungbluth H.; Zhou H.; Hartley L.; Halliger-Keller B.; Messina S.; Longman C.; Brockington M.; Robb S.A.; Straub V.; Voit T.; Swash M.; Ferreiro A.; Bydder G.; Sewry C.A.; Mueller C.; Muntoni F.;
Neurology 65:1930-1935(2005)
Cited for: VARIANTS CMYP1B TRP-109 AND LYS-2423; VARIANTS VAL-485 AND CYS-2060; Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores.
Monnier N.; Marty I.; Faure J.; Castiglioni C.; Desnuelle C.; Sacconi S.; Estournet B.; Ferreiro A.; Romero N.; Laquerriere A.; Lazaro L.; Martin J.-J.; Morava E.; Rossi A.; Van der Kooi A.; de Visser M.; Verschuuren C.; Lunardi J.;
Hum. Mutat. 29:670-678(2008)
Cited for: VARIANTS CMYP1B VAL-13; SER-1704; PRO-2421; LYS-2423; HIS-3539; GLN-3772; GLN-4558; MET-4842 AND ILE-4849;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.